Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Google Inc (GOOG) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

Google IncTrade
Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Google Inc vs Vaxcyte Inc. Common Stock — how do they compare? Google Inc trades at $338.8 (market cap $4.30T), while Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B). The key difference: Google Inc is far larger — about 409.1× Vaxcyte Inc. Common Stock's market cap, and Google Inc pays a 0.25% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Google Inc for 138 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

GOOGPCVX
Market Cap
$4.30T$10.51B
Volume
14,394,0612,644,694
Sector
MediaHealth
52-Week High
$399.06$73.82
52-Week Low
$251.34$40.32
Typical Hold Time
138 Days0 Days
Enterprise Value
$4.19T$9.14B
Dividend Yield
0.25%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Google Inc

Alphabet (GOOG) trades at $349.52, up 0.16% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust revenue growth to $402.84 billion in 2025, with net income surging to $132.17 billion and a net margin of 32.8%. Recent earnings beats and a consensus analyst price target of $435.29 highlight investor confidence, though high capital expenditures and legal challenges present near-term risks.

The outlook for GOOG remains positive driven by AI and cloud expansion, with projected 2026 revenue of $445.9 billion. However, rising capex leading to negative free cash flow projections and ongoing securities lawsuits pose significant risks. The stock's current valuation metrics, including a P/E of 17.54, suggest room for growth if execution continues, but investors should weigh these factors against the competitive and regulatory landscape.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GOOG
29% Buy71% Sell
Avg holding period · 138 Days
PCVX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Google Inc

Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.

Read more on GOOG →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →